Induction of apoptosis in rat hepatocarcinoma cells by expression of IGF-I antisense c-DNA

Journal of Hepatology

Volumn 29, Issue 5, 1998, Pages 807-818

  Ellouk Achard, Sophie ^a,c   Djenabi, Sepideh ^a   De Oliveira, Gilberto Antonio ^a   Desauty, Geneviève ^a   Thien Duc, Huynh ^b   Zohair, Mishal ^a   Trojan, Jerzy ^b   Claude, Jean Roger ^c   Sarasin, Alain ^a   Lafarge Frayssinet, Christiane ^a  

^a CNRS   (France)

^b HÔPITAL PAUL BROUSSE   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Apoptosis; Comet assay; DNA fragmentation; Flow cytometry; Gene therapy; Hepatocarcinoma; IGF I; In vitro

Indexed keywords

DNA FRAGMENT; METALLOTHIONEIN; SOMATOMEDIN C;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION FUNCTION; DNA CONTENT; EXPERIMENTAL NEOPLASM; FLOW CYTOMETRY; GENE THERAPY; IN VITRO STUDY; LIVER CELL CARCINOMA; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; RAT;

EID: 17044450254     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80263-8     Document Type: Article

References (40)

1. Han VKM, Hill DJ. Structure and biological functions. Shofield PN. The Insulin-like Growth Factors. 1992;178-219 Oxford University Press, Oxford, England.
2. Benito M, Valverde AM, Lorenzo M. IGF-I: a mitogen also involved in differentiation processes in mammalian cells. Int J Biochem Cell Biol. 28:1996;499-510.
3. Sell C, Dumenil G, Deveaud C, Miura M, Coppola D, De Angelis T, et al. Effect of a null mutation of the type I IGF receptor gene on growth and transformation of mouse embryo fibroblasts. Mol Cell Biol. 14:1994;3604-3612.
4. Baserga R. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res. 55:1995;249-252.
5. Rubin R, Baserga R. Biology of disease. Insulin-like growth factor I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity. Lab Invest. 73:1995;311-331.
6. Trojan J, Blossey BK, Johnson TR, Rudin SD, Tykocinsky M, Ilan Ju, et al. Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense DNA transcription of insulin-like growth factor I. Proc Natl Acad Sci USA. 89:1992;4874-4878.
7. Trojan J, Johnson TR, Rudin SD, Ilan Ju, Tykocinsky M, Ilan J. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science. 259:1993;94-97.
8. Resnicoff M, Sell C, Rubini M, Coppola D, Ambrose D, Baserga R, et al. Rat glioblastoma cells expressing an anti-sense RNA to the insulin-like growth factor I (IGF-I) receptor are non tumorigenic and induce regression of wild-type tumors. Cancer Res. 54:1994;2218-2222.
9. Trojan J, Johnson TR, Rudin SD, Blossey BK, Kelley KM, Shevelev A, et al. Gene therapy of murine teratocarcinoma: separate functions for insulin-like growth factors I and II in immunogenicity and differentiation. Proc Natl Acad Sci USA. 91:1994;6088-6092.
10. Resnicoff M, Coppola D, Sell C, Rubin F, Ferrone SD, Baserga R. Growth inhibition of human melanoma cells in nude mice by antisense strategies to the types insulin-like growth factor receptor. Cancer Res. 54:1994;4848-4850.
11. C Lafarge-Frayssinet, Sarasin A, Duc HT, Frayssinet C, Johnson TR, Ilan J, et al. Gene therapy for hepatocarcinoma: antisense IGF-I transfer into a rat hepatoma cell line inhibits tumorigenesis into syngeneic animal. Cancer Gene Ther. 4:1997;276-285.
12. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennisson A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg. 218:1993;145-151.
13. Bruix J. Treatment of hepatocellular carcinoma. Hepatology. 25:1993;259-262.
14. Cassingena R, Lafarge-Frayssinet C, Painchault V, Estrade S, Nardeux R, Frayssinet C. Methionine independence, tumorigenicity and oncogene expression of rat hepatocarcinoma cells. Biol Cell. 69:1990;113-118.
15. Lafarge-Frayssinet C, Cassingena R, Frayssinet C, Estrade S, Havouis R, Moulinoux JP. Polyamine content and oncogene expression in hepatoma cells in culture during methionine deprivation and refeeding. Anticancer Res. 13:1993;491-496.
16. Baserga R. Oncogenes and the strategy of growth factors. Cell. 79:1994;927-930.
17. Baserga R, Sell C, Porcu P, Rubini M. The role of IGF-I receptor in the growth and transformation of mammalian cells. Cell Prolif. 27:1994;63-78.
18. Harrington EA, Bennett MR, Fanidi A, Evan GI. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13:1994;3286-3295.
19. Sell C, Baserga R, Rubin R. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res. 55:1995;303-306.
20. Resnicoff M, Abraham D, Yutanawiboonchai W, Rotman HL, Kajustora J, Rubin R, et al. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res. 55:1995;2463-2469.
21. Trojan J, Uriel J, Deugnien MA, Gaillard J. Immunocytochemical quantification study of alphafetoprotein in normal and neoplastic development. Dev Neuros. 6:1984;251-259.
22. Dive C, Gregory CD, Phipps DJ, Evans DL, Milner AE, Wyllie AH. Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochem Biophys Acta. 1133:1992;275-285.
23. 2+ indicators with greatly improved fluorescence properties. J. Biol Chem. 160:1985;3440-3450.
24. 2+ channels. Trends Pharmacol Sci. 12:1991;349-356.
25. Ellouk-Achard S, Mawet E, Thibault N, Dutertre-Catella H, Thevenin M, Claude JR. Protective effect of nifedipine against cytotoxicity and intracellular calcium alterations induced by acetaminophen in rat hepatocyte cultures. Drug Chem Toxicol. 18:1995;105-117.
26. Pollack A, Ciancio G. Cell cycle phase-specific analysis of cell viability using Hœchst 33342 and propidium iodide after ethanol preservation. Darzynkiewicz Z, Crissman HA. Flow Cytometry. 1991;19-24 Academic Press, San Diego.
27. Singh NP, Tice RR, Stephens RE, Schneider EL. A microgel electrophoresis technique for the direct quantification of DNA damage and repair in individual fibroblast cultured on microscope slides. Mut Res. 252:1991;289-296.
28. Alapetite C, Wachter T, Sage E, Moustacchi E. Use of the alkaline comet assay to detect DNA repair deficiencies in human fibrosis exposed to UVC, UVB, UVA and γ-rays. Int J Radiat Biol. 69:1996;359-369.
29. Telford WG, King LE, Fraker PJ. Rapid quantification of apoptosis in pure and heterogeneous cell populations using flow cytometry. J Immunol Meth. 172:1994;1-16.
30. Arends MJ, Morris RG, Wyllie AH. Apoptosis: the role of endonuclease. Am J Pathol. 136:1990;593-608.
31. Wyllie AH, Arends MJ, Morris RG, Walker SW, Evan G. The apoptosis endonuclease and its regulation. Semin Immunol. 4:1992;389-398.
32. Compton MM. A biochemical hallmark of apoptosis: internucleosomal degradation of the genome. Cancer Metast Rev. 11:1992;105-119.
33. Gorczyca W, Tuziak T, Kram A, Melamed MR, Darynkiewicz Z. Detection of apoptosis-associated DNA strand breaks in fine needle aspiration biopsies by in situ end labeling of fragmented DNA. Cytometry. 15:1994;169-175.
34. Orrenius S, McConkey DJ, Bellomo G, Nicotera P. Role of calcium in toxic cell killing. Trends Pharmacol Sci. 7:1989;281-285.
35. Nicotera P, Zhivotovsky B, Orrenius S. Nuclear calcium transport and the role of calcium in apoptosis. Cell Calcium. 18:1990;279-288.
36. Kaleko M, Rutter WG, Miller AD. Overexpression of the human insulin-like growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol Cell Biol. 10:1990;464-473.
37. Sara VR, Hall K. Insulin-like growth factors and their binding proteins. Physiol Rev. 70:1990;591-614.
38. Rodriguez-Tarduchy G, Collins MKL, Garcia I, Lopez-Rivas A. Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells. Eur J Immunol. 149:1992;535-540.
39. D'Ambrosio C, Ferber A, Resnicoff M, Baserga R. A soluble insulin-like growth factor-receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Cancer Res. 56:1996;4013-4020.
40. Feldman G. Liver apoptosis. J Hepatol. 26:1997;1-11.